Summary:

• The global interventional cardiology and peripheral vascular devices market size reached USD 25.0 Billion in 2023.
• The market is expected to reach USD 47.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.07% during 2024-2032.
• North America leads the market, accounting for the largest interventional cardiology and peripheral vascular devices market share due to its advanced healthcare infrastructure and high healthcare expenditure.
• Based on the product type, the market has been divided into difficult inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts.
• On the basis of indication, the market has been bifurcated into coronary intervention and peripheral arterial disease.
• Geriatric accounts for the majority of the market share in the age group segment as they have higher prevalence of chronic conditions and complex health needs.
• Hospitals holds the largest share in the interventional cardiology and peripheral vascular devices industry as they handle majority of inpatient and outpatients.
• The rising prevalence of cardiovascular diseases across the globe is a primary driver of the interventional cardiology and peripheral vascular devices market.
• Technological advancements and the increasing demand for minimally invasive procedures are further reshaping the interventional cardiology and peripheral vascular devices market.

Request for a sample copy of this report: https://www.imarcgroup.com/interventional-cardiology-peripheral-vascular-devices-market/requestsample

Industry Trends and Drivers:

• Growing Prevalence of Cardiovascular Diseases:

The rising incidence of cardiovascular diseases (CVDs) is a major factor propelling the interventional cardiology and peripheral vascular devices market share. Factors like sedentary lifestyles, unhealthy diets, smoking, and increased stress levels have led to an alarming rise in conditions like coronary artery disease, stroke, and peripheral artery disease. The geriatric population is especially susceptible to these diseases, with age-related factors like hypertension and diabetes compounding the risk. As a result, there’s growing demand for effective treatments that include minimally invasive interventions like angioplasty, stenting, and other catheter-based procedures. This surge in CVD prevalence not only increases the demand for interventional cardiology devices but also fuels the development of new, innovative solutions to improve patient outcomes.

• Rising Demand for Minimally Invasive Procedures:

The growing preference for minimally invasive procedures is a significant factor boosting the interventional cardiology and peripheral vascular devices market size. Minimally invasive techniques, such as balloon angioplasty, stent placement, and atherectomy, are increasingly favored over traditional open surgeries due to their many advantages. These procedures typically involve smaller incisions, reduced blood loss, and shorter hospital stays, leading to quicker recovery times and a lower risk of complications. Patients are drawn to the promise of less post-operative pain and faster returns to normal activity, while healthcare providers benefit from decreased hospital costs and the ability to treat more patients. Advances in device technology, including the development of more flexible and precise catheters and stents, have made minimally invasive interventions safer and more effective, further driving the market.

• Technological Advancements:

Technological advancements are another critical driver of growth in the interventional cardiology and peripheral vascular devices market. Innovations in device design, materials, and functionality have significantly improved the safety, efficacy, and precision of interventional procedures. Drug-eluting stents, for instance, have transformed coronary interventions by reducing the risk of restenosis, while bioresorbable vascular scaffolds offer a temporary framework that naturally dissolves, restoring normal vessel function. Additionally, the advent of next-generation imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), has enhanced real-time visualization during procedures, allowing physicians to accurately place devices and assess treatment outcomes. These advancements not only improve procedural success rates but also reduce complications, leading to faster patient recovery times.

Interventional Cardiology and Peripheral Vascular Devices Market Report Segmentation:

IMARCs report provides a deep dive into the interventional cardiology and peripheral vascular devices market analysis, outlining the current trends, underlying market demand, and growth trajectories.

Breakup By Product Type:

• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Accessories
• Angioplasty Balloons
• Angioplasty Stents
• Angioplasty Catheters
• Endovascular Aneurysm Repair Stent Grafts

Based on the product type, the market has been divided into difficult inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts.

Breakup By Indication:

• Coronary Intervention
• Peripheral Arterial Disease

On the basis of indication, the market has been bifurcated into coronary intervention and peripheral arterial disease.

Breakup By Age Group:

• Geriatric
• Adults
• Paediatric

Geriatric represents the majority of shares as they have a higher prevalence of chronic conditions and complex health needs.

Breakup By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Hospitals hold the majority of shares as they handle the majority of inpatient and outpatient treatments.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America holds the leading position owing to its advanced healthcare infrastructure and high healthcare expenditure.

Top Interventional Cardiology and Peripheral Vascular Devices Market Leaders:

The interventional cardiology and peripheral vascular devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

• Abbott Laboratories
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Group Incorporated
• Cordis Corporation
• Koninklijke Philips N.V.
• Medtronic plc.
• Teleflex Incorporated
• Terumo Corporation

Ask Analyst & Browse full report with TOC List of Figures: https://www.imarcgroup.com/request?type=report&id=7542&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145